drugset / Trial / NCT01298700
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the long-term safety of bimatoprost 0.01% ophthalmic solution compared with bimatoprost 0.03% ophthalmic solution in patients with glaucoma or ocular hypertension.
Timeline
- Start
- 2011-05-31
- Primary completion
- 2016-12-06
- Completion
- 2016-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.01 % | Other |
| Subject | Bimatoprost | Other / unclassified | 0.03 % | Other |